NutraLife Biosciences Inc NLBS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.04
- Bid/Ask
- $0.02 / $0.03
- Market Cap
- $17,662.32
- Volume/Avg
- 750 / 31,362
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
NutraLife BioSciences Inc is engaged in the development, manufacturing and distribution of nutritional and dietary nutritional supplement products. The company is a branded and private label developer, manufacturer and distributor of a wide range of nutraceutical, wellness, and CBD products. It's private-label ingestible and skincare products include CBD-infused oral sprays, tinctures, pet drops, pain balms, and face creams. Its CBD products are derived from the seeds and mature stalks of the Cannabis Sativa plant which includes all parts and varieties of the cannabis sativa plant also known as hemp, which contain a tetrahydrocannabinol concentration.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 12
Valuation
|
Metric
|
NLBS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
NLBS
Financial Strength
|
Metric
|
NLBS
|
|---|---|
Quick Ratio | 0.11 |
Current Ratio | 0.20 |
Interest Coverage | −1.15 |
Quick Ratio
NLBS
Profitability
|
Metric
|
NLBS
|
|---|---|
Return on Assets (Normalized) | −72.52% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −104.82% |
Return on Assets
NLBS
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Ffrhjmdsq | Dvqwfp | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Lrmdpkdbx | Rtp | $68.3 Bil | |
HLN
| Haleon PLC ADR | Tgqlmfyz | Xdtts | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Kfktjblj | Wknhb | $14.7 Bil | |
VTRS
| Viatris Inc | Vmdcyyrrc | Tdgdj | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jtldlvcmt | Vtkq | $11.9 Bil | |
CTLT
| Catalent Inc | Bcplcfs | Lkxvjh | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Gygkmqn | Nllp | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Bctptcltx | Vrfx | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Lzscbvpt | Zvnwmn | $3.5 Bil |